3Ozalp S,Yalcin OT,Oner U,et al. Microvessel Densily as a Prognostic Factor in Preinvasive and Invasive Cervical Lesions[J].Eur J Gynaecol Oncol,2003,24(5):425 -428.
4Folkman J. New Perspectives in Clinical Oncology from Angiogenesis Research[J]. Eur J Cancer, 1996,32(14) : 2534-2539.
5Wiggins D, Granai CO, Steinhoff MM, et al. Tumor Angiogenesis as a Prognostic Factor in Cervical Carcinoma[J]. Gynecol Oncol, 1995,56(3) :353-356.
6Obermair A, Wanner C, Bilgi S, et al. Tumor Angiogenesis in Stage IB Cervical Cancer:Correlation of Microvessel Density with Survival[J]. AMJ Obstet Gynecol,1998,178(2) :314-319.
7Luiten RM, Fleuren GJ, Warnaar SO, et al. Target-specific Activa tion of Mast Cells by Immunoglobulin Ereactive with a Renal Cell Carcinoma Associated Antigen[J]. Lab Invest, 1996,74 (2) : 467-475.
8Fenando IN, Moskovic E, Fryatt I, et al. Is there still a role for lymphography in the management of early stage carcinoma of the cervix? Br J Radiol, 1994, 67 : 1052-1056.
9Lien HH. MR imaging of invasive carcinoma of the uterine cervix. Acta Radiol, 1999, 40:236-245.
10Yang WT, Lam WW, Yu MY, et al. Comparison of dynamic helical CT and dynamic MR imaging in the evaluation of pelvic lymph nodes in cervical carcinoma. AJR Am J Roentgenol, 2000, 175:759-766.
